Docprime Technologies, a subsidiary of PB Fintech Ltd. which also owns Policybazaar and Paisabazaar, on Monday said it has invested approximately $7.5 million in telehealth and wellness platform, Visit Health.
This marks Docprime’s first investment in an end-to-end telehealth and wellness platform. Five-year old Visit Health provides an integrated solution which helps corporations provide their employees access to certified specialists, while helping them manage their healthcare needs. The platform empowers enterprises to enhance the healthcare experience and optimize medical costs for all their employees.
The investment will help PB Fintech enhance its service capabilities in the health and wellness space, it said in a statement.
“Our goal with this investment is to back Visit Health in their vision to build a strong Digital Health Ecosystem - with outstanding customer service and new ways to help customers navigate a healthcare system. We are proud to back Visit as they approach their next phase of growth," said Yashish Dahiya, chairman and chief executive officer, PB Fintech.
Docprime, launched by Policybazaar’s parent in August 2018, allows users to book appointments with doctors and diagnostic labs through its platform. The platform also acts as an agent, facilitator, for various healthcare, wellness products, and personal care products.
“Visit is excited to have PB Fintech as a partner in our strategic vision to create a Digital Health Ecosystem. Our product offering is backed by Health insurers and the large cashless network stitched by us. With this investment, we plan to grow our platform and network capabilities and expand our teams across technology, sales, and network functions," said Visit Health’s chief executive officer, Anurag Prasad on the acquisition.
Visit Health had earlier raised $1.4 million as a part of its seed fundraise, and is backed by the likes of Snapdeal founders Kunal Bahl and Rohit Bansal, and Hetero Drugs Director Murali Krishna.
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
